Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy

Alessandro Puzziello, Mario Carrano, Elisabetta Angrisani, Vincenzo Marotta, Antongiulio Faggiano, Pio Zeppa, Mario Vitale

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Non-suppressive or partially suppressive L-T4 treatment demonstrated to be effective in reducing the volume of the nodules. However, studies with long follow-up are lacking and significant controversy exists regarding the efficacy of non-suppressive L-T4 treatment in benign nodular goiter. Aim: The goal of this study was to determine the evolution of thyroid nodules in subjects treated with a non-suppressive levothyroxine (L-T4) dose, compared to untreated subjects. Design and patients: We followed for a period of 1-9 years the thyroid nodule size in 356 female patients in the age range 19-45 at study entry, of which 201 untreated (Group 0) and 165 treated with a non-suppressive L-T4 dose (Group L-T4). Measurements: We determined the volume of thyroid nodules by ultrasonography. Results: The initial mean nodule volume in Group 0 and Group L-T4 was 3.91 ± 6.87 and 4.01 ± 7.35 mL, respectively. Nodule volume increase was inversely correlated to the initial volume. The final volume was slightly higher in untreated than in L-T4 treated subjects (5.37 ± 8.49 and 4.39 ± 6.72 mL). In both groups, the mean of annual fold increase of nodule volume was inversely correlated with the follow-up duration (P <0.0046), indicating a slower growth as time advances. In the subjects treated with L-T4, the mean annual increase of nodule volume was significantly minor compared to untreated subjects. Concomitant nodules in ten multinodular goiters exhibited totally independent evolution, demonstrating that intranodular factors are more important for the nodule behavior than extra nodular factors. Conclusions: Our study demonstrates that the growth of benign thyroid nodules is inversely correlated to their size, benign nodules naturally growth slowly as time advances, and that a chronic treatment with L-T4 at a non-TSH-suppressive dose significantly reduces their growth.

Original languageEnglish
Pages (from-to)1181-1186
Number of pages6
JournalJournal of Endocrinological Investigation
Volume37
Issue number12
DOIs
Publication statusPublished - Dec 7 2014

Fingerprint

Thyroid Nodule
Thyroxine
Growth
Nodular Goiter
Goiter
Therapeutics
Ultrasonography

Keywords

  • Benign nodular goiter
  • Keyterms: Thyroid
  • Levothyroxine
  • Ultrasonography

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Puzziello, A., Carrano, M., Angrisani, E., Marotta, V., Faggiano, A., Zeppa, P., & Vitale, M. (2014). Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy. Journal of Endocrinological Investigation, 37(12), 1181-1186. https://doi.org/10.1007/s40618-014-0128-z

Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy. / Puzziello, Alessandro; Carrano, Mario; Angrisani, Elisabetta; Marotta, Vincenzo; Faggiano, Antongiulio; Zeppa, Pio; Vitale, Mario.

In: Journal of Endocrinological Investigation, Vol. 37, No. 12, 07.12.2014, p. 1181-1186.

Research output: Contribution to journalArticle

Puzziello, A, Carrano, M, Angrisani, E, Marotta, V, Faggiano, A, Zeppa, P & Vitale, M 2014, 'Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy', Journal of Endocrinological Investigation, vol. 37, no. 12, pp. 1181-1186. https://doi.org/10.1007/s40618-014-0128-z
Puzziello A, Carrano M, Angrisani E, Marotta V, Faggiano A, Zeppa P et al. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy. Journal of Endocrinological Investigation. 2014 Dec 7;37(12):1181-1186. https://doi.org/10.1007/s40618-014-0128-z
Puzziello, Alessandro ; Carrano, Mario ; Angrisani, Elisabetta ; Marotta, Vincenzo ; Faggiano, Antongiulio ; Zeppa, Pio ; Vitale, Mario. / Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy. In: Journal of Endocrinological Investigation. 2014 ; Vol. 37, No. 12. pp. 1181-1186.
@article{e660048f52b9487c9c5cd26991611023,
title = "Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy",
abstract = "Background: Non-suppressive or partially suppressive L-T4 treatment demonstrated to be effective in reducing the volume of the nodules. However, studies with long follow-up are lacking and significant controversy exists regarding the efficacy of non-suppressive L-T4 treatment in benign nodular goiter. Aim: The goal of this study was to determine the evolution of thyroid nodules in subjects treated with a non-suppressive levothyroxine (L-T4) dose, compared to untreated subjects. Design and patients: We followed for a period of 1-9 years the thyroid nodule size in 356 female patients in the age range 19-45 at study entry, of which 201 untreated (Group 0) and 165 treated with a non-suppressive L-T4 dose (Group L-T4). Measurements: We determined the volume of thyroid nodules by ultrasonography. Results: The initial mean nodule volume in Group 0 and Group L-T4 was 3.91 ± 6.87 and 4.01 ± 7.35 mL, respectively. Nodule volume increase was inversely correlated to the initial volume. The final volume was slightly higher in untreated than in L-T4 treated subjects (5.37 ± 8.49 and 4.39 ± 6.72 mL). In both groups, the mean of annual fold increase of nodule volume was inversely correlated with the follow-up duration (P <0.0046), indicating a slower growth as time advances. In the subjects treated with L-T4, the mean annual increase of nodule volume was significantly minor compared to untreated subjects. Concomitant nodules in ten multinodular goiters exhibited totally independent evolution, demonstrating that intranodular factors are more important for the nodule behavior than extra nodular factors. Conclusions: Our study demonstrates that the growth of benign thyroid nodules is inversely correlated to their size, benign nodules naturally growth slowly as time advances, and that a chronic treatment with L-T4 at a non-TSH-suppressive dose significantly reduces their growth.",
keywords = "Benign nodular goiter, Keyterms: Thyroid, Levothyroxine, Ultrasonography",
author = "Alessandro Puzziello and Mario Carrano and Elisabetta Angrisani and Vincenzo Marotta and Antongiulio Faggiano and Pio Zeppa and Mario Vitale",
year = "2014",
month = "12",
day = "7",
doi = "10.1007/s40618-014-0128-z",
language = "English",
volume = "37",
pages = "1181--1186",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "12",

}

TY - JOUR

T1 - Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy

AU - Puzziello, Alessandro

AU - Carrano, Mario

AU - Angrisani, Elisabetta

AU - Marotta, Vincenzo

AU - Faggiano, Antongiulio

AU - Zeppa, Pio

AU - Vitale, Mario

PY - 2014/12/7

Y1 - 2014/12/7

N2 - Background: Non-suppressive or partially suppressive L-T4 treatment demonstrated to be effective in reducing the volume of the nodules. However, studies with long follow-up are lacking and significant controversy exists regarding the efficacy of non-suppressive L-T4 treatment in benign nodular goiter. Aim: The goal of this study was to determine the evolution of thyroid nodules in subjects treated with a non-suppressive levothyroxine (L-T4) dose, compared to untreated subjects. Design and patients: We followed for a period of 1-9 years the thyroid nodule size in 356 female patients in the age range 19-45 at study entry, of which 201 untreated (Group 0) and 165 treated with a non-suppressive L-T4 dose (Group L-T4). Measurements: We determined the volume of thyroid nodules by ultrasonography. Results: The initial mean nodule volume in Group 0 and Group L-T4 was 3.91 ± 6.87 and 4.01 ± 7.35 mL, respectively. Nodule volume increase was inversely correlated to the initial volume. The final volume was slightly higher in untreated than in L-T4 treated subjects (5.37 ± 8.49 and 4.39 ± 6.72 mL). In both groups, the mean of annual fold increase of nodule volume was inversely correlated with the follow-up duration (P <0.0046), indicating a slower growth as time advances. In the subjects treated with L-T4, the mean annual increase of nodule volume was significantly minor compared to untreated subjects. Concomitant nodules in ten multinodular goiters exhibited totally independent evolution, demonstrating that intranodular factors are more important for the nodule behavior than extra nodular factors. Conclusions: Our study demonstrates that the growth of benign thyroid nodules is inversely correlated to their size, benign nodules naturally growth slowly as time advances, and that a chronic treatment with L-T4 at a non-TSH-suppressive dose significantly reduces their growth.

AB - Background: Non-suppressive or partially suppressive L-T4 treatment demonstrated to be effective in reducing the volume of the nodules. However, studies with long follow-up are lacking and significant controversy exists regarding the efficacy of non-suppressive L-T4 treatment in benign nodular goiter. Aim: The goal of this study was to determine the evolution of thyroid nodules in subjects treated with a non-suppressive levothyroxine (L-T4) dose, compared to untreated subjects. Design and patients: We followed for a period of 1-9 years the thyroid nodule size in 356 female patients in the age range 19-45 at study entry, of which 201 untreated (Group 0) and 165 treated with a non-suppressive L-T4 dose (Group L-T4). Measurements: We determined the volume of thyroid nodules by ultrasonography. Results: The initial mean nodule volume in Group 0 and Group L-T4 was 3.91 ± 6.87 and 4.01 ± 7.35 mL, respectively. Nodule volume increase was inversely correlated to the initial volume. The final volume was slightly higher in untreated than in L-T4 treated subjects (5.37 ± 8.49 and 4.39 ± 6.72 mL). In both groups, the mean of annual fold increase of nodule volume was inversely correlated with the follow-up duration (P <0.0046), indicating a slower growth as time advances. In the subjects treated with L-T4, the mean annual increase of nodule volume was significantly minor compared to untreated subjects. Concomitant nodules in ten multinodular goiters exhibited totally independent evolution, demonstrating that intranodular factors are more important for the nodule behavior than extra nodular factors. Conclusions: Our study demonstrates that the growth of benign thyroid nodules is inversely correlated to their size, benign nodules naturally growth slowly as time advances, and that a chronic treatment with L-T4 at a non-TSH-suppressive dose significantly reduces their growth.

KW - Benign nodular goiter

KW - Keyterms: Thyroid

KW - Levothyroxine

KW - Ultrasonography

UR - http://www.scopus.com/inward/record.url?scp=84940946953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940946953&partnerID=8YFLogxK

U2 - 10.1007/s40618-014-0128-z

DO - 10.1007/s40618-014-0128-z

M3 - Article

C2 - 25008459

AN - SCOPUS:84940946953

VL - 37

SP - 1181

EP - 1186

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 12

ER -